Iron Dextran and Injectable Iron in Canada: Top 5 Options for 2026
Published on Tuesday, January 27, 2026
Iron dextran refers to a class of injectable iron treatments used to correct moderate to severe iron deficiency anemia when oral iron is not tolerated, not effective, or when rapid repletion is needed. In Canada these products are used in hospital and clinic settings for patients with chronic kidney disease, inflammatory bowel disease, heavy menstrual bleeding, postpartum anemia, or preoperative anemia protocols. Consumers and clinicians in Canada favor injectable iron for its faster restoration of hemoglobin and iron stores, lower incidence of gastrointestinal side effects compared with oral iron, and convenient dosing options that can reduce the need for repeated daily pills. Key decision factors in Canadian markets include safety profile, provincial formulary coverage, single-visit dosing versus multiple infusions, product availability, and local clinician experience. This category page highlights what to know about iron dextran and related intravenous iron products, and how Canadians typically choose between brands such as Dexiron, Infufer, CosmoFer, INFeD, and Ferrlecit.
Top Picks Summary
Dexiron
Dexiron is positioned as a cost-conscious iron dextran option, often selected by hospitals and clinics seeking a lower-priced generic alternative to established brands. It competes on price and basic efficacy with branded dextran products like CosmoFer and INFeD, though buyers should consider potential variability in manufacturing and supply chain quality versus long-standing market leaders.
Infufer
Infufer is a non-dextran ferric carboxymaltose product that stands out for its ability to deliver larger iron doses in shorter infusion times and with a lower risk of dextran-related hypersensitivity. Although typically pricier than iron dextran formulations, its technical advantage of faster repletion and fewer clinic visits can produce downstream cost savings compared with dextran-based therapies.
CosmoFer
CosmoFer is an established low-molecular-weight iron dextran with a long track record in intravenous iron replacement, offering clinicians a well-documented balance of efficacy and safety for larger single-dose administrations. It often represents the middle ground between cheaper generics like Dexiron and newer non-dextran agents, combining familiar dosing flexibility with lower reported reaction rates than older high-molecular-weight dextrans.
INFeD
INFeD is a widely used iron dextran formulation particularly familiar to U.S. hospital formularies, prized for its ability to deliver total-dose iron infusions when clinically appropriate. Its market strength comes from established procurement channels and reimbursement recognition, though it shares the dextran-class considerations of required monitoring and slower infusion compared with some non-dextran alternatives.
Ferrlecit
Ferrlecit (sodium ferric gluconate) is a non-dextran intravenous iron product frequently used in dialysis and chronic kidney disease settings because of a generally favorable safety profile regarding dextran-related reactions. While it typically cannot match iron dextran products for very large single-dose replacement, its predictable tolerability and strong adoption in renal care make it a practical alternative to consider alongside dextran formulations.
What the Research Says: Benefits and Safety of Injectable Iron
Clinical research and international guidelines support the use of intravenous iron for specific patient groups who need more rapid or reliable iron repletion than oral therapy can provide. Randomized trials and meta-analyses have shown that IV iron produces faster increases in hemoglobin and ferritin compared with oral iron, reduces the need for blood transfusion in surgical and obstetric settings, and improves fatigue and quality of life measures in many patients. Safety data emphasize that most modern IV iron formulations have low rates of serious allergic reactions when administered correctly, though rare hypersensitivity can occur. Older high molecular weight iron dextran products were associated with higher anaphylaxis risk, which led to practice changes and broader use of low molecular weight dextran or non-dextran formulations with improved tolerability. Health care providers follow evidence-based monitoring and infusion protocols to minimize risk and select the formulation best suited to the patient and clinical setting.
IV iron restores hemoglobin and iron stores more quickly than oral iron in many patients.
Studies show IV iron can reduce transfusion needs in preoperative and obstetric care.
Modern formulations have a low incidence of severe allergic reactions when administered under supervision.
Older high molecular weight iron dextran had higher anaphylaxis risk; this influenced product choice and monitoring practices.
Clinical guidelines recommend IV iron for patients who do not respond to or cannot tolerate oral iron, and for some chronic conditions such as CKD and inflammatory bowel disease.
Frequently Asked Questions
Which injectable iron is best for patients needing rapid symptom relief?
Infufer is the preferred choice for rapid repletion because it allows for large single doses of up to 1000 mg per infusion, providing quick symptom relief with a lower risk of hypersensitivity compared to traditional dextran products.
Does CosmoFer have a higher safety rating than other iron dextrans?
CosmoFer holds an average rating of 4.5, making it the highest-rated option among the listed iron dextrans due to its low-molecular-weight formulation designed to reduce the risk of severe hypersensitivity reactions.
Is Dexiron a cheaper alternative for hospital iron replacement?
Dexiron is positioned as a cost-conscious generic alternative to established brands like CosmoFer and INFeD, specifically designed for hospitals and clinics seeking a lower-priced option for multi-dose or total-dose iron infusion regimens.
Are there specific monitoring requirements for using Dexiron in clinics?
Dexiron requires monitored administration and may necessitate a test dose before full treatment due to the inherent risk of hypersensitivity reactions associated with its iron dextran formulation.
Conclusion
In Canada the injectable iron category includes a range of options — Dexiron, Infufer, CosmoFer, INFeD, and Ferrlecit — each with different dosing schedules, formulation histories, and local availability. For many Canadian patients and clinics, CosmoFer (iron sucrose) is often considered the best overall choice among these five due to its established safety and predictable dosing profile, but individual needs, provincial formularies, and clinician preference will affect the final selection. We hope this guide helped you understand injectable iron options and find what you were looking for. You can refine or expand your search using the search to compare dosing, safety notes, provincial coverage, and clinic availability.